Form D · Biotechnology

Betaliq Inc

Tarpon Springs, FL · CIK 0001772435

Offering snapshot reported Jun 2, 2025 · SEC filing

Reported sold
$416K
Offering amount: $5M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 21, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 2, 2025Initial$416,270No comparison8SEC filing
Jul 26, 2019Amendment$6,001,965$0vs Apr 4, 201968SEC filing
Apr 4, 2019Initial$6,001,965No comparison67SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$29.7K
Finders' fees
$0
Form D file number
021-547821

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Arcadia Securities, LLC44656
Collage Venture Partners, LLC316063

Source: Form D, filed Jun 2, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Barry Butler Director, Executive
Christopher Jones Director
Haley Lemon Executive
Christian Roesky Director
Albert Rudick Director
Oliver Schlueter Director, Executive
Oliver Schluter Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
905 E Martin Luther King Jr. Drive Suite 240
Tarpon Springs, FL, 34689